A consortium of venture capital firms has invested in a $40m series-B funding round for Swiss biotechnology company Anokion.
Combined group will operate a network of 155 dental clinics and generate revenues of around €100m
Before joining the Paris-based team, David Revcolevschi was partner at Paul Hastings and Freshfields
Abénex draws capital from its Abénex V fund, which closed on €425m in December 2017
GP co-invests with VC Zobito and will combine the business with Verdane IX portfolio company Dapresy